Clinical Trial

Extracorporeal Shock Wave Therapy in Patients With Lipedema

Study acronym: LIPO-ESWT
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
Lipedema is a chronic adipose tissue disorder characterized by pain, tenderness, disproportionate fat accumulation, and impaired quality of life. Extracorporeal shock wave therapy (ESWT) has been proposed as a non-invasive treatment option that may improve pain and tissue characteristics in patients with lipedema. The aim of this prospective interventional study is to evaluate the effects of ESWT on pain intensity, quality of life, functional outcomes, and ultrasonographic findings in patients diagnosed with lipedema. Participants will receive a standardized ESWT protocol consisting of six treatment sessions over a two-week period. Clinical assessments and ultrasonographic examinations will be performed before and after treatment.
Trial Details
NCT Number NCT07683559
Lead Sponsor Atlas University
Conditions Lipedema
Enrollment 40 participants
Start Date 2026-07-01
Primary Completion 2026-12-01 (estimated)
Study Completion 2027-01-01 (estimated)
Updated on ClinicalTrials.gov 2026-07-06